Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (With 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety
This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasib…
Refractory AnginaCoronary Artery Disease
XyloCor Therapeutics, Inc.NCT07048808
Observational
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated…
Refractory Angina
Shockwave Medical, Inc.NCT05102019